Safeway Inc. et al v. Abbott Laboratories

Filing 88

ORDER re (183 in 4:07-cv-05985-CW) GRANTING STIPULATION Re Fact Discovery on Certain Items After Cut-Off; (129 in 4:07-cv-05702-CW) GRANTING STIPULATION Re Fact Discovery on Certain Items After Cut-Off; (77 in 4:07-cv-06120-CW) GRANTING STIPULATION Re Fact Discovery on Certain Items After Cut-Off ; (87 in 4:07-cv-05470-CW) GRANTING STIPULATION Re Fact Discovery on Certain Items After Cut-Off. Signed by Judge CLAUDIA WILKEN on 2/25/09. (scc, COURT STAFF) (Filed on 2/25/2009)

1 2 3 4 5 6 7 8 9 10
101 California Street San Francisco, CA 94111-5802

James F. Hurst (Admitted Pro Hac Vice) David J. Doyle (Admitted Pro Hac Vice) Samuel S. Park (Admitted Pro Hac Vice) Stephanie S. McCallum (Admitted Pro Hac Vice) WINSTON & STRAWN LLP 35 W. Wacker Drive Chicago, IL 60601-9703 Telephone: [phone] Facsimile: 312-558-5700 Email: [e-mail]; [e-mail]; [e-mail]; [e-mail] Nicole M. Norris (SBN 222785) WINSTON & STRAWN LLP 101 California Street, Suite 3900 San Francisco, CA 94111-5894 Telephone: [phone] Facsimile: 415-591-1400 Email: [e-mail]

Jeffrey I. Weinberger (SBN 56214) David M. Rosenzweig (SBN 176272) Grant A. Davis-Denny (SBN 229335) MUNGER, TOLLES & OLSON LLP 355 Grand Avenue Los Angeles, CA 90071-1560 Telephone: [phone] Facsimile: [phone] Email: [e-mail]; [e-mail]; [e-mail] Michelle Friedland (SBN 234124) MUNGER, TOLLES & OLSON LLP 560 Mission Street, 27th Floor San Francisco, CA 94105-2907 Telephone: [phone] Facsimile: [phone] Email: [e-mail]

11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Charles B. Klein (Admitted Pro Hac Vice) Attorneys for Defendant Mathew A. Campbell (Admitted Pro Hac Vice) ABBOTT LABORATORIES WINSTON & STRAWN LLP 1700 K Street, N.W. Washington, D.C. 20007 Telephone: [phone] Facsimile: 202-282-5100 Email: [e-mail] UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA OAKLAND DIVISION SAFEWAY INC., et al, Plaintiffs, v. ABBOTT LABORATORIES, Defendant. ) ) ) ) ) ) ) ) ) ) ) ) ) Case No. C07-5470 (CW) Related per November 19, 2007 Order to Case No. C04-1511 (CW) ORDER GRANTING STIPULATION RE FACT DISCOVERY ON CERTAIN ITEMS AFTER CUT-OFF

Winston & Strawn LLP

(Caption continued on next page.)

STIPULATION RE FACT DISCOVERY ON CERTAIN ITEMS AFTER CUT-OFF CASE NOS. C07-5470, C07-5702, C07-5985, C07-6012 (CW)
SF:237141.1

1 2 3 4 5 6 7 8 9 10
101 California Street San Francisco, CA 94111-5802

11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

SMITHKLINE BEECHAM CORPORATION ) d/b/a GLAXOSMITHKLINE, ) ) Plaintiff, ) ) v. ) ) ABBOTT LABORATORIES, ) ) Defendant. ) ) ) ) ) ) ) MEIJER, INC. & MEIJER DISTRIBUTION, ) INC., et al., ) ) Plaintiffs, ) ) v. ) ) ABBOTT LABORATORIES, ) ) Defendant. ) ) ) ) ) ) ) RITE AID CORPORATION, et al., ) ) Plaintiffs, ) ) v. ) ) ABBOTT LABORATORIES, ) ) Defendant. ) ) ) ) ) ) )

Case No. C07-5702 (CW) (Consolidated Cases) Related per November 19, 2007 Order to Case No. C04-1511 (CW)

Case No. C07-5985 (CW) (Consolidated Cases) Related per November 30, 2007 Order to Case No. C04-1511 (CW)

Winston & Strawn LLP

Case No. 07-6120 (CW) Related per December 5, 2007 Order to Case No. C04-1511 (CW)

STIPULATION RE FACT DISCOVERY ON CERTAIN ITEMS AFTER CUT-OFF CASE NOS. C07-5470, C07-5702, C07-5985, C07-6012 (CW)
SF:237141.1

1 2 3 4 5 6 7 8 9 10
101 California Street San Francisco, CA 94111-5802

WHEREAS, the parties are engaged in fact discovery in the consolidated cases of Safeway, et al., v. Abbott Laboratories (No. 07-5470), Smithkline Beecham Corp. d/b/a Glaxosmithkline v. Abbott Laboratories (No. 07-5702), Meijer, Inc. & Meijer Distribution, Inc., et al. v. Abbott Laboratories (No. 07-5985), and Rite Aid Corp., et al., v. Abbott Laboratories (No. 07-6120); WHEREAS, the fact discovery cut-off is presently set for February 27, 2009; WHEREAS, the parties have worked diligently to complete fact discovery, but seek relief for certain discrete items that are specifically listed below that cannot be completed within the present cut-off; WHEREAS, the modest extension of fact discovery for these discrete items will not affect the other scheduled dates previously set by this Court (including expert discovery, summary judgment, and trial). IT IS HEREBY STIPULATED AND AGREED: 1. The deadline to respond to written discovery issued in January 2009 for all parties

11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Winston & Strawn LLP

shall be extended from the end of February until March 13, 2009. Without waiving any arguments or rights arising from any non-compliance with prior orders of the court, the deadline for Abbott to supplement responses to Plaintiffs' costs and profits document requests, originally served on May 2, 2008 and September 2, 2008, shall be extended from the end of February until March 13, 2009. Any motions to compel relating to any discovery covered by this paragraph shall be filed by March 20, 2009. 2. The parties will work together to provide mutually convenient dates for the Rule

30(b)(1) depositions of Laureen Cassidy, Jeff Morgan and William Calhoun as well as the Rule 30(b)(6) deposition of GSK as soon as possible in March 2009. The depositions of Laureen Cassidy and William Calhoun shall be limited to 5 hours each. 3. GSK reserves the right to file a motion for protective order as to Abbott's Rule

30(b)(6) deposition notice and Abbott reserves the right to file a motion to compel on that notice. Any such motion should be initially filed in the form of a 2-page letter brief before Judge Zimmerman on or before March 20, 2009. If GSK files such a motion and Judge Zimmerman 1
STIPULATION RE FACT DISCOVERY FOR CERTAIN ITEMS AFTER CUT-OFF CASE NOS. C07-5470, C07-5702, C07-5985, C07-6012 (CW)
SF:237141.1

1 2 3 4 5 6 7 8 9 10
101 California Street San Francisco, CA 94111-5802

allows that deposition to go forward, the parties will work together to provide mutually convenient dates for the GSK witness(es) designated under Rule 30(b)(6) as soon as possible in March 2009. 4. The parties shall work together to agree to a stipulation regarding the authentication

of documents. Abbott reserves the right to file a motion for protective order as to GSK's Requests for Admission and GSK reserves its right to file a motion to compel responses to GSK's Requests for Admissions on or before March 20, 2009. Any such motion should initially be filed in the form of a 2-page letter brief before Judge Zimmerman. 5. Plaintiffs will not object to the production of documents from subpoenaed third

parties Vertex, PCI and BMS as long as those documents are produced 14 days in advance of the date for opening expert reports. Abbott may attempt to authenticate those documents by soliciting self-authenticating affidavits from those third parties. Within fourteen days of receiving copies of all such affidavits, Plaintiffs will inform Abbott as to whether they intend to challenge those affidavits under FRE 902(11). If Plaintiffs intend to challenge such affidavits, Abbott may thereafter schedule a deposition of such third parties, with such depositions to be scheduled no later than sixty days before trial. Also, within fourteen days of receiving all productions from third parties, Plaintiffs may move the Court for leave to take follow-on discovery from third parties. 6. The direct purchaser class, Safeway, and Rite Aid plaintiffs shall have until 30 days

11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Winston & Strawn LLP

after the close of expert discovery to serve supplemental responses to Interrogatory Nos. 4-5 and 7-8 (direct purchasers) 3-4, and 6 (Safeway and Rite Aid) contained in Abbott's First Set of Interrogatories to each such plaintiff group. Abbott shall have 21 days after the service of any such supplemental responses in which to move to compel further responses, if necessary. 7. Nothing in this stipulation shall expand or limit the parties' rights to issue any

additional discovery beyond February 27, 2009, except as set forth herein. /// /// ///

2
STIPULATION RE FACT DISCOVERY FOR CERTAIN ITEMS AFTER CUT-OFF CASE NOS. C07-5470, C07-5702, C07-5985, C07-6012 (CW)
SF:237141.1

1 2 3 4 5 6 7 8 9 10
101 California Street San Francisco, CA 94111-5802

IT IS SO STIPULATED, THROUGH COUNSEL OF RECORD:

/s/ Lauren Ravkind Lauren Ravkind KENNY NACHWALTER, PA 1100 Miami Center 201 South Biscayne Blvd. Miami FL 33131 Attorneys for Safeway, Inc. /s/ John D. Radice John D. Radice KAPLAN FOX & KILSHEIMER LLP 850 Third Avenue New York, NY 10011 Attorneys for Meijer, Inc /s/ Andrew E. Aubertine Andrew E. Aubertine AUBERTINE DRAPER ROSE LLP 1211 SW Sixth Avenue Portland, Oregon 97204 Attorneys for Louisiana Wholesale Drug Company, Inc. /s/ Trevor Stockinger Trevor Stockinger IRELL & MANELLA 1800 Avenue of the Stars Suite 900 Los Angeles, CA 90067-4276 Attorneys for GSK

/s/ Charles B. Klein Charles B. Klein WINSTON & STRAWN LLP 1700 K Street, N.W. Washington, D.C. 20007 Attorneys for Defendant Abbott Laboratories /s/ Daniel C. Simons Daniel C. Simons BERGER & MONTAGUE, P.C. 1622 Locust Street Philadelphia, PA 19103-6305 Attorneys for Rochester Drug CoOperative, Inc. /s/ Monica L. Rebuck Monica L. Rebuck HANGLEY ARONCHICK SEGAL & PUDLIN 30 N. Third Street, Suite 700 Harrisburg, PA 17101 Attorneys for Rite Aid, Inc.

11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 3

Winston & Strawn LLP

PURSUANT TO STIPULATION, IT IS SO ORDERED 2/25/09 Dated: _______________________

Judge Claudia Wilken United States District Court Northern District of California

STIPULATION RE FACT DISCOVERY FOR CERTAIN ITEMS AFTER CUT-OFF CASE NOS. C07-5470, C07-5702, C07-5985, C07-6012 (CW)
SF:237141.1